|
|
 |
 |
 Fukuoka
is Your First Step to Success in All of Asia |
With close collaboration with other Asian
nations in mind, Fukuoka is promoting the creation of new industries
centered on biotechnology, providing support for new biotechnology
companies, and working toward the formation of a large biotechnology
cluster comprised of biotech-related firms and research institutions.
 |
Fukuoka provides an optimal base for your
pharmaceutical business with its excellent support programs
and pharmaceutical development infrastructure.Centered on the Clinical Research Support Center Kyushu, nine university hospitals in Kyushu have organized a clinical testing network that provides high-quality clinical data specifically tailored to your time and scale needs. |
 |
|
Fukuoka provides the optimal base for the
pharmaceutical business in Asia. Its universities are
training specialists in biotechnology statistics and providing
support for companies through the expert advice of patent
and pharmaceutical development advisors. |
|
Fukuoka offers a gateway to pharmaceuticals markets in other Asian countries through its convenient transportation network and excellent human resources. |
|
|
Fukuoka is a center for advanced cancer
research. Kurume University is at the forefront of research
on liver cancer and hepatitis treatments. The university
hosts an annual forum on liver cancer research with researchers
from South Korea and China and conducts pioneering studies
in tailored health care fields with the support of the
Japanese national government. The university is also the
birthplace of a start-up company that develops tailored
peptide vaccines for liver cancer. The university is proof
positive of Fukuoka's potential as a hub for innovation
in cancer treatment research and related areas. |
|
| Support |
Fukuoka
Bio Valley Project
In April 2004, the Fukuoka
Bio Incubation Center (F-BIC) opened as a center specifically
dedicated to biotechnology research. The F-BIC has incubation
managers and business coordinators who provide support for the
commercialization of research seeds introductions to business
partners, and offer other services free of charge to support
the creation of new pharmaceuticals. The Kurume University Medical
School, Biotechnology and Food Research Institute, Fukuoka Industrial
Technology Center and other biotechnology-related research institutions
are located near the Center, offering excellent opportunities
for joint research.
Moreover, in spring 2007, Fukuoka Bio Factory, a rental factory for bio-ventures to produce biochips and reagents, opened. Being the Japan’s first plant specifically dedicated to bio production, the plant offers strong support for foreign bio companies’ business development. |
Fukuoka
Bio Incubation Center |
Fukuoka Bio Factory |
| Major Companies |
|
Kyushu Medical Co., Ltd. :
Recently began operations at its Indonesia plant, which manufactures
and sells nutritional feed supplements that reduce the risk
of infection from viruses in aquaculture shrimps. Its business
is expanding throughout Asia. |
|
GNI Ltd. :
Developing the information analysis system of "transcriptome"
to support the creation of genome-based pharmaceuticals. |
|
Astec Co., Ltd.
:
Manufacturing, selling and importing scientific medical equipment
for biotechnology-related research and development. |
|
Iberica Co., Ltd.
:
Supporting clinical testing and research, translational research, biotechnology statistics, etc. Promoting its business globally,
with offices in Tokyo, Osaka and in the U.S. |
|
I. S.T. Co., Ltd. :
Developed the world-first reagent that shows fluorescence in dry state. Operating in the US. |
|
Aqumen Biopharmaceuticals, K. K. :
Developing treatment agents for Age-related Macular Degeneration (AMD), a cause of blindness. Conducting clinical tests to obtain US FDA approval. |
|
Ecogenomics, Inc. :
Developed a DNA chip for assessment of chemicals using medaka (Japanese killifish) as index. Expanding business in the US. |
| |
For more -----  |
|
